{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-22-000551","form_type":"8-K","ticker":"CRL","cik":"0001100682","company_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","filed_at":"2022-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.743043+00:00","generated_at":"2026-06-26T00:23:51.423395+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Charles River Q1 revenue $913.9M (+10.8%), GAAP EPS $1.81, non-GAAP EPS $2.75","bullets":["Q1 revenue $913.9M (+10.8% YoY); organic growth 9.4%; GAAP net income $93.0M (+51.2%); non-GAAP net income $141.1M (+9.3%).","Segment revenue: RMS $176.5M (flat), DSA $544.3M (+8.6%), Manufacturing $193.1M (+31.8% driven by CDMO acquisitions).","2022 guidance updated: reported revenue growth raised to 13.5%-15.5% (from 13-15%); organic growth unchanged 12.5%-14.5%; non-GAAP EPS reaffirmed $11.50-$11.75.","DSA segment reported record booking activity and strong backlog growth, with studies booked into 2023.","Foreign currency reduced reported revenue growth by 1.7%; acquisitions contributed 4.7%."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-22-000551","json":"https://secwatch.observer/filing/0001157523-22-000551.json","markdown":"https://secwatch.observer/filing/0001157523-22-000551.md","text":"https://secwatch.observer/filing/0001157523-22-000551.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1100682/000115752322000551/0001157523-22-000551-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1100682/000115752322000551/a52706413.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T00:23:51.423395+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}